The multifaceted actions of angiostatin, from downregulating VEGF expression to disrupting cell signaling pathways and inducing apoptosis, highlight its potential as a promising antiangiogenic agent in tumor growth and metastasis [110]. The gene discussed is VEGFA; the disease is neoplasm.